Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
International Journal of Dermatology
|
March 11, 2004
Immunoglobulin therapy: history, indications, and routes of administration
Catherine R Weiler
The Journal of Allergy and Clinical Immunology. in Practice
|
September 10, 2019
Omalizumab and Mast Cell Disorders: Are We There Yet?
Catherine R Weiler
The Journal of Allergy and Clinical Immunology. in Practice
|
August 31, 2019
Mast Cell Activation Syndrome: Tools for Diagnosis and Differential Diagnosis
Catherine R Weiler
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
July 25, 2021
How good are mast cell mediators?
Catherine R Weiler
The Journal of Allergy and Clinical Immunology. in Practice
|
July 8, 2019
Mastocytosis, Quinolones, MRGPRX2, and Anaphylaxis
Catherine R Weiler
International Journal of Dermatology
|
February 3, 2007
Anisakis simplex and cross-reacting antigens
Catherine R Weiler
The Journal of Allergy and Clinical Immunology. in Practice
|
March 7, 2020
The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome
Joseph Butterfield, Catherine R Weiler
Immunology and Allergy Clinics of North America
|
April 22, 2014
Mast cell sarcoma: clinical management
Catherine R Weiler, Joseph Butterfield
The Journal of Allergy and Clinical Immunology. in Practice
|
October 11, 2020
Accurate Diagnosis and Prognosis in Systemic Mastocytosis: The Role of Mutational Analysis
Catherine R Weiler, Cem Akin
International Archives of Allergy and Immunology
|
December 17, 2013
Presentation of untreated systemic mastocytosis as recurrent, pulseless-electrical-activity cardiac arrests resistant to cardiac pacemaker
Joseph H Butterfield, Catherine R Weiler
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
International Journal of Dermatology
|
March 11, 2004
Immunoglobulin therapy: history, indications, and routes of administration
Catherine R Weiler
The Journal of Allergy and Clinical Immunology. in Practice
|
September 10, 2019
Omalizumab and Mast Cell Disorders: Are We There Yet?
Catherine R Weiler
The Journal of Allergy and Clinical Immunology. in Practice
|
August 31, 2019
Mast Cell Activation Syndrome: Tools for Diagnosis and Differential Diagnosis
Catherine R Weiler
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
July 25, 2021
How good are mast cell mediators?
Catherine R Weiler
The Journal of Allergy and Clinical Immunology. in Practice
|
July 8, 2019
Mastocytosis, Quinolones, MRGPRX2, and Anaphylaxis
Catherine R Weiler
International Journal of Dermatology
|
February 3, 2007
Anisakis simplex and cross-reacting antigens
Catherine R Weiler
The Journal of Allergy and Clinical Immunology. in Practice
|
March 7, 2020
The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome
Joseph Butterfield, Catherine R Weiler
Immunology and Allergy Clinics of North America
|
April 22, 2014
Mast cell sarcoma: clinical management
Catherine R Weiler, Joseph Butterfield
The Journal of Allergy and Clinical Immunology. in Practice
|
October 11, 2020
Accurate Diagnosis and Prognosis in Systemic Mastocytosis: The Role of Mutational Analysis
Catherine R Weiler, Cem Akin
International Archives of Allergy and Immunology
|
December 17, 2013
Presentation of untreated systemic mastocytosis as recurrent, pulseless-electrical-activity cardiac arrests resistant to cardiac pacemaker
Joseph H Butterfield, Catherine R Weiler
Page
of 4